Date: March 13, 2024 By: Nick Kolev
About the Program
The Catherine Othieno Sempa* Memorial Post Baccalaureate Scholars Program engages talented college graduates from HBCUs and Puerto Rican universities in a comprehensive and immersive two-year program in immunology research.
The program is designed to diversify the field of academic research by inviting recent college graduates to gain knowledge, expertise, and skills inside and outside the lab.
Program Benefits
Participants will be employed as paid, full-time Research Technicians under the supervision and mentorship of a Ragon Institute Principal Investigator and/or designated Post-Doctoral Research Fellow. Participants will receive a competitive salary and benefits consistent with employment as a Research Technician at the Institute. In addition, participants will engage in academic and professional development activities including:
Participants will also receive a $3,000 travel allowance.
Program Eligibility
This program is open to individuals from Historically Black Colleges and Universities (HBCUs) and students from Puerto Rican Universities. Applicants must meet the following criteria:
How to Apply
After an initial screening by the Ragon Institute Office of Education and Outreach, applications will be reviewed by a Ragon Institute selection committee, and prospective candidates will be interviewed. Selected candidates will be then matched with labs with open positions for final appointments.
Deadlines
Application deadline: April 19, 2024
Start date: June-August 2024
Researchers at the Ragon Institute of Mass General Brigham, MIT, and Harvard have uncovered critical insights into how aging impairs the immune system’s ability to fight cancer.
This study, published in Immunity on August 30, used a non-human primate model to demonstrate that previous Mtb infection leads to a durable, protective immune response that is dependent on CD4+ T cells.
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.